Related Experiment Video
Updated: Oct 3, 2026
Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
Published on: October 13, 2023
Primary malignant lymphoma of the parotid gland report of three cases
M E Stein1, A Brunnel, D Lewis
1Department of Clinical Oncology and Radiotherapy, Oldchurch Hospital, Romford, UK. m_stein@rambam.health.gov.il
Aims And Background:
To document the clinicopathologic features and treatment modalities of primary malignant parotid gland lymphoma, based on three cases diagnosed and treated at Oldchurch Hospital, Romford, UK.
Methods:
Three patients, two with stage II and one with stage IV disease, received primary treatment consisting of chemotherapy following surgical biopsy.
Results:
All three patients obtained rapid complete remission during their scheduled chemotherapy. One patient is alive without evidence of disease 12 months from the end of treatment. One patient, a frail, elderly gentleman, died due to massive pneumonia while in complete remission for two months. The third patient, who developed local recurrences in both parotid glands without transformation of his low-grade histology, achieved a second complete remission following chemo- and radiotherapy. All side effects were of a mild nature.
Conclusion:
Malignant lymphoma of the parotid gland is a chemo- and radiosensitive disease.